ID   OCI-AML3/HaABCG2 clone 3.3
AC   CVCL_D6NG
RX   PubMed=12393637;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 2978; DNMT3A; Simple; p.Arg882Cys (c.2644C>T); ClinVar=VCV000375882; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; 74; ABCG2.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1844 ! OCI-AML-3
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=12393637; DOI=10.1182/blood-2002-01-0271;
RA   Abbott B.L., Colapietro A.-M., Barnes Y.-X.E., Marini F.C.,
RA   Andreeff M., Sorrentino B.P.;
RT   "Low levels of ABCG2 expression in adult AML blast samples.";
RL   Blood 100:4594-4601(2002).
//